Page 123 - 2022-33-中国全科医学
P. 123
·4216· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn
[3]JARNUM S,JENSEN H. Diffuse gastrointestinal polyposis with [16]KIM M S,JUNG H K,JUNG H S,et al. A case of Cronkhite-
ectodermal changes. A case with severe malabsorption and enteric loss Canada syndrome showing resolution with Helicobacter pylori
of plasma proteins and electrolytes[J]. Gastroenterology,1966, eradication and omeprazole[J]. Korean J Gastroenterol,2006,
50(1):107-118. 47(1):59-64. DOI:10.4166/kjg.2021.059.
[4]GOTO A. Cronkhite-Canada syndrome:epidemiological study of 110 [17]DAWRA S,SHARMA V,DUTTA U. Clinical and endoscopic
cases reported in Japan[J]. Nihon Geka Hokan,1995,64(1):3-14. remission in a patient with Cronkhite-Canada syndrome[J]. Clin
[5]OBA M S,MURAKAMI Y,NISHIWAKI Y,et al. Estimated Gastroenterol Hepatol,2018,16(8):e84-85. DOI:10.1016/j.
prevalence of cronkhite-Canada syndrome,chronic enteropathy cgh.2017.09.023.
associated with SLCO 2 A1 gene,and intestinal behçet's disease in [18]PATIL V,PATIL L S,JAKAREDDY R,et al. Cronkhite-
Japan in 2017:a nationwide survey[J]. J Epidemiol,2021,31(2): Canada syndrome:a report of two familial cases[J]. Indian J
139-144. DOI:10.2188/jea.JE20190349. Gastroenterol,2013,32(2):119-122. DOI:10.1007/s12664-
[6]WEN X H,WANG L,WANG Y X,et al. Cronkhite-Canada 012-0296-8.
syndrome:report of six cases and review of literature[J]. World J [19]BOLAND B S,BAGI P,VALASEK M A,et al. Cronkhite Canada
Gastroenterol,2014,20(23):7518-7522. DOI:10.3748/wjg. syndrome:significant response to infliximab and a possible clue to
v20.i23.7518. pathogenesis[J]. Am J Gastroenterol,2016,111(5):746-
[7]OTA S,KASAHARA A,TADA S,et al. Cronkhite-Canada 748. DOI:10.1038/ajg.2016.92.
syndrome showing elevated levels of antinuclear and anticentromere
[20]LIU S,YOU Y,CHEN D,et al. Cronkhite-Canada syndrome
antibody[J]. Clin J Gastroenterol,2015,8(1):29-34. DOI:
complicated with three malignant tumors:a case report and whole
10.1007/s12328-014-0547-6.
exome sequencing analysis[J]. Chin Med J (Engl),2019,132(24):
[8]SLAVIK T,MONTGOMERY E A. Cronkhite-Canada syndrome
3001-3002. DOI:10.1097/CM9.0000000000000508.
six decades on:the many faces of an enigmatic disease[J].
[21]ZHU L P,ZHONG W L,WANG Z G,et al. Cronkhite-
J C l i n Pa t ho l ,2014,67(10):891-897. DOI:
Canada syndrome:an investigation in clinical features and
10.1136/jclinpath-2014-202488.
pathogenesis[J]. J Dig Dis,2021,22(11):663-671. DOI:
[9]WU Z Y,SANG L X,CHANG B. Cronkhite-Canada syndrome:
10.1111/1751-2980.13062.
from clinical features to treatment[J]. Gastroenterol Rep (Oxf),
[22]BURKE A P,SOBIN L H. The pathology of Cronkhite-Canada
2020,8(5):333-342. DOI:10.1093/gastro/goaa058.
polyps. A comparison to juvenile polyposis[J]. Am J Surg
[10]KIDOGUCHI K,KUBOTA Y,FUJIMOTO S,et al. Aplastic
Pathol,1989,13(11):940-946. DOI:10.1097/00000478-
Anemia in a patient with cronkhite-Canada syndrome[J]. Intern
198911000-00004.
Med,2021,60(10):1601-1605. DOI:10.2169/internalmedi
[23]DANIEL E S,LUDWIG S L,LEWIN K J,et al. The Cronkhite-
cine.6468-20.
Canada syndrome. An analysis of clinical and pathologic features and
[11]SWEETSER S,AHLQUIST D A,OSBORN N K,et al.
therapy in 55 patients[J]. Medicine (Baltimore),1982,61(5):
Clinicopathologic features and treatment outcomes in Cronkhite-
293-309.
Canada syndrome:support for autoimmunity[J]. Dig Dis Sci,
[24]WATANABE D,OOI M,HOSHI N,et al. Successful treatment
2012,57(2):496-502. DOI:10.1007/s10620-011-1874-9.
of Cronkhite-Canada syndrome using anti-tumor necrosis factor
[12]RIEGERT-JOHNSON D L,OSBORN N,SMYRK T,et al.
antibody therapy[J]. Endoscopy,2014,46(Suppl 1
Cronkhite-Canada syndrome hamartomatous polyps are infiltrated
UCTN):E476-477. DOI:10.1055/s-0034-1377539.
with IgG4 plasma cells[J]. Digestion,2007,75(2/3):96-
[25]LIU S,YOU Y,RUAN G C,et al. The long-term clinical
97. DOI:10.1159/000102963.
and endoscopic outcomes of Cronkhite-Canada syndrome[J].
[13]JHA A K,KUMAR A,SINGH S K,et al. Panendoscopic
Clin Transl Gastroenterol,2020,11(4):e00167. DOI:
characterization of Cronkhite-Canada syndrome[J]. Med J Armed
Forces India,2018,74(2):196-200. DOI:10.1016/j. 10.14309/ctg.0000000000000167.
mjafi.2017.03.007. [26]SWEETSER S,ALEXANDER G L,BOARDMAN L A. A case
[14]BANDYOPADHYAY D,HAJRA A,GANESAN V,et al. of Cronkhite-Canada syndrome presenting with adenomatous and
Cronkhite-Canada syndrome:a rare cause of chronic diarrhoea in a inflammatory colon polyps[J]. Nat Rev Gastroenterol Hepatol,
young man[J]. Case Rep Med,2016,2016:4210397. DOI: 2010,7(8):460-464. DOI:10.1038/nrgastro.2010.112.
10.1155/2016/4210397. [27]WARD E M,WOLFSEN H C. Pharmacological management of
[15]OKAMOTO K,ISOMOTO H,SHIKUWA S,et al. A case of Cronkhite-Canada syndrome[J]. Expert Opin Pharmacother,
Cronkhite-Canada syndrome:remission after treatment with anti- 2003,4(3):385-389. DOI:10.1517/14656566.4.3.385.
Helicobacter pylori regimen[J]. Digestion,2008,78(2/3): (收稿日期:2022-02-14;修回日期:2022-04-16)
82-87. DOI:10.1159/000165354. (本文编辑:崔莎)